chr9-136723031-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152421.4(DIPK1B):āc.553A>Gā(p.Lys185Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152421.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIPK1B | ENST00000371692.9 | c.553A>G | p.Lys185Glu | missense_variant | 5/5 | 1 | NM_152421.4 | ENSP00000360757.4 | ||
DIPK1B | ENST00000371691.5 | c.292A>G | p.Lys98Glu | missense_variant | 3/3 | 1 | ENSP00000360756.1 | |||
SNHG7 | ENST00000414282.5 | n.692T>C | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152210Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000140 AC: 35AN: 250324Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135608
GnomAD4 exome AF: 0.0000897 AC: 131AN: 1461112Hom.: 0 Cov.: 34 AF XY: 0.000105 AC XY: 76AN XY: 726870
GnomAD4 genome AF: 0.000138 AC: 21AN: 152210Hom.: 0 Cov.: 34 AF XY: 0.000108 AC XY: 8AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.553A>G (p.K185E) alteration is located in exon 5 (coding exon 5) of the FAM69B gene. This alteration results from a A to G substitution at nucleotide position 553, causing the lysine (K) at amino acid position 185 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at